Loading…
eosinophilic esophagitis
esophagitis characterized by inflammation involving eosinophils located in esophagus
Details
- Instance of
- designated intractable/rare disease, type of disease
- Subclass of
- esophagitis, gastrointestinal allergy
- drug or therapy used for treatment
- fluticasone
- health specialty
- gastroenterology
- ICD-9-CM
- 530.13
- symptoms and signs
- inflammation
Connected on Wikidata
Subject of
- Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
- Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
- Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis
- Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
- Topical Steroid Treatment for Eosinophilic Esophagitis
- An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients
- Budesonide for Eosinophilic Esophagitis
- Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
- Data Bank for Eosinophilic Disorders
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
- Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
Nothing in the MetaHistoryBook collection references this item yet.